Photo by nci from unsplash
I have read with great interest the case report entitled “Epicardially placed implantable cardioverter-defibrillator for a child with congenital long QT syndrome” by Sugiyama et al. in the latest issue… Click to show full abstract
I have read with great interest the case report entitled “Epicardially placed implantable cardioverter-defibrillator for a child with congenital long QT syndrome” by Sugiyama et al. in the latest issue of the journal [1]. The authors well presented a case of long QT syndrome managed using implantation of an epicardial shock electrode and dose titration of beta-blocker therapy. However, some important issues should be mentioned. As compared to beta-blocker therapy with metoprolol, treatment with nadolol has been shown to significantly decrease breakthrough cardiac events in symptomatic patients [2]. Furthermore,
Journal Title: Journal of Arrhythmia
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!